Author Archives: JAIDS

Immunodeficiency at the Start of Combination Antiretroviral Therapy: Steady Improvement or…

No abstract available

Posted in Journal Watch | Comments closed

Depressive Symptoms by HIV Serostatus Are Differentially Associated With Unprotected Receptive…

No abstract available

Posted in Journal Watch | Comments closed

Evaluation of the Efficacy and Safety of Switching to Tenofovir, Emtricitabine, and Rilpivirine…

No abstract available

Posted in Journal Watch | Comments closed

Test, Treat, and Cure

No abstract available

Posted in Journal Watch | Comments closed

Association Between Latent Toxoplasmosis and Psychiatric Disorders in HIV-Infected Subjects

No abstract available

Posted in Journal Watch | Comments closed

“If I Take My Medicine, I Will Be Strong: ” Evaluation of a Pediatric HIV Disclosure

800px-USMC-120211-M-HG547-137

Background: Despite known benefits, only a small proportion of HIV-infected children in sub-Saharan Africa know their status and limited disclosure interventions exist.

Posted in Featured Content, HIV/AIDS, Infant & Child Health, Journal Watch | Comments closed

Longitudinal Trends in HIV Nonoccupational Postexposure Prophylaxis Use at a Boston Community…

Abstract: Secular trends in nonoccupational postexposure prophylaxis (NPEP) use have not been well characterized.

Posted in Journal Watch | Comments closed

HIV and STI Prevalence and Risk Factors Among Male Sex Workers and Other Men Who Have Sex With…

Abstract: Previous surveys of men who have sex with men (MSM) in Africa have not adequately profiled HIV status and risk factors by sex work status.

Posted in Journal Watch | Comments closed

Maternal HIV Status Associated With Under-Five Mortality in Rural Northern Malawi: A…

Background: Under-five mortality is decreasing but with little change in neonatal mortality rates.

Posted in Journal Watch | Comments closed

Changes in Metabolic Syndrome Status After Initiation of Antiretroviral Therapy

Image Anti-Retroviral-AIDS-Drug-008.jpg

Background: Data on changes in metabolic syndrome (MetS) status in HIV-infected adults on antiretroviral therapy (ART) are limited.

Posted in Cardiovascular, Diabetes, Featured Content, HIV/AIDS, Journal Watch | Comments closed

Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High-Income…

Background: The CD4 cell count or percent (CD4%) at the start of combination antiretroviral therapy (cART) is an important prognostic factor in children starting therapy and an important indicator of program performance.

Posted in Journal Watch | Comments closed

HIV Disease Progression in Seroconvertors from the CAPRISA 004 Tenofovir Gel Pre-exposure…

Background: Although antiretroviral pre-exposure prophylaxis prevents HIV acquisition, it is not known if it alters HIV disease progression.

Posted in Journal Watch | Comments closed

Transmission Clustering Among Newly Diagnosed HIV Patients in Chicago, 2008 to 2011: Using…

Introduction: HIV transmission cluster analyses can inform HIV prevention efforts.

Posted in Journal Watch | Comments closed

Changes in Bone Mineral Density After 96 Weeks of Treatment With Atazanavir/Ritonavir or…

Abstract: Antiretroviral therapy initiation is associated with declines in bone mineral density (BMD), which seem greatest with tenofovir disoproxil fumarate (DF)–containing regimens.

Posted in Journal Watch | Comments closed